Biden admin freezes Trump HHS rule meant to lower insulin prices

Biden admin freezes Trump HHS rule meant to lower insulin prices

President
Biden
has
been
reversing
or
pausing
some
rules
put
in
place
under
former

President
Donald
Trump
this
week,
including
one
designed
to
bring
down
the
price
of
insulin.

The

Department
of
Health
and
Human
Services
on
Thursday
announced
that
the
directive would
be
put
on
hold
among
a
number
of
other
measures
that
were
passed
under
Trump,
but
are
not
yet
in
effect.

BIDEN
EXECUTIVE
ORDERS
THE
‘WISHLIST
OF
THE
FAR
LEFT,’
RUBIO
SAYS

The
measure,
signed
off
on
in
December,
aimed
to
require
some
community
health
centers
to
deliver
savings
to
low-income
patients
for
insulin
and
epinephrine
in
a
bid
to
bring
down
unaffordable
prices.

CLICK
HERE
TO
GET
THE
FOX
NEWS
APP 

The
rule
was
scheduled
to
go
into
effect
on
Friday
but
has
since
been
delayed
until
March
22.

On
Wednesday,
White
House
chief
of
staff
Ron
Klain
directed
agencies
to
pause
orders
signed
towards
the
end
of
Trump’s
term
so
they
could
be
reviewed.

The
order
directs
the
administration
to
immediately
withdraw
rules
that
have
been
sent
to
the
Office
of
Financial
Research
but
not
yet
published
in
the
Federal
Register.
For
those
that
have
been
published,
but
are
not
yet
effective,
members
are
directed
to
“consider
postponing
the
rules’
effective
dates
for
60
days.”

Category Latest Posts